# High-risk HPV among 44,000 women in Tashkent, Andijan and Samarkand

Source: https://onco.cc/key-papers/paper-oltieva-high-risk-hpv-44000-women-uzbekistan-bmcid-2025/  
OnCo record `paper-oltieva-high-risk-hpv-44000-women-uzbekistan-bmcid-2025` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Among 44,497 women attending gynaecological services in three regions in 2021 to 2023, 8.5% carried high-risk HPV, and HPV 16 or 18, the types the vaccine prevents, accounted for 41.1% of infections.

## Summary

Published as "Epidemiology of high-risk HPV in Uzbekistan among 44,000 women - genotypes, risk profiles and screening needs in Uzbekistan". Women aged 20 and over attending gynaecological services in Tashkent, Andijan and Samarkand had liquid-based cytology and HPV DNA testing for 12 high-risk types.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: BMC Infectious Diseases
- Year: 2025
- DOI: 10.1186/s12879-025-12096-7
- Authors: Oltieva MP, Alieva DA, Abdusattorova SB, et al.
- Findings: High-risk HPV was found in 3,779 women (8.5%): 9.2% in Andijan, 8.8% in Tashkent and 6.5% in Samarkand.; 52.8% of infections were mixed; HPV 16 or 18 accounted for 41.1%.; Among HPV-positive women with cytology, 6.9% had HSIL and 0.3% carcinoma.
- What it means: HPV prevalence data from three Uzbek regions, supporting HPV-based screening and vaccination.
- Caveats: Women attending services, not a random population sample.

## Sources

- BMC Infect Dis 2025: https://doi.org/10.1186/s12879-025-12096-7
- PubMed: https://pubmed.ncbi.nlm.nih.gov/41402780/

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- institutions: [Republican Specialized Scientific-Practical Medical Center of Maternal and Child Health (Uzbekistan)](https://onco.cc/institutions/uzbekistan-maternal-child-health-center/)

---
JSON: https://onco.cc/api/v1/entities/paper-oltieva-high-risk-hpv-44000-women-uzbekistan-bmcid-2025.json